(Q88978493)

English

First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients

scientific article (preprint)

Statements

0 references
0 references
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients (English)
0 references
Hongyi Chen
0 references
Zhicheng Zhang
0 references
Li Wang
0 references
Zhihua Huang
0 references
Fanghua Gong
0 references
Xiaodong Li
0 references
Yahong Chen
0 references
Jinzi J. WU
0 references
24 March 2020
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit